These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16504505)

  • 1. Bradykinin antagonists modified with dipeptide mimetic beta-turn inducers.
    Alcaro MC; Vinci V; D'Ursi AM; Scrima M; Chelli M; Giuliani S; Meini S; Di Giacomo M; Colombo L; Papini AM
    Bioorg Med Chem Lett; 2006 May; 16(9):2387-90. PubMed ID: 16504505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New bradykinin B(2) receptor antagonists - influence of C-terminal segment modifications on their pharmacological properties.
    Sleszyńska M; Kwiatkowska A; Sobolewski D; Wierzba TH; Katarzyńska J; Zabrocki J; Borovickova L; Slaninová J; Prahl A
    Acta Biochim Pol; 2009; 56(4):641-8. PubMed ID: 19997652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of bradykinin B(2) receptor agonists containing constrained dipeptide mimics.
    Amblard M; Daffix I; Bergé G; Calmès M; Dodey P; Pruneau D; Paquet JL; Luccarini JM; Bélichard P; Martinez J
    J Med Chem; 1999 Oct; 42(20):4193-201. PubMed ID: 10514289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationship studies of PTH(1-11) analogues containing sterically hindered dipeptide mimetics.
    Fiori N; Caporale A; Schievano E; Mammi S; Geyer A; Tremmel P; Wittelsberger A; Woznica I; Chorev M; Peggion E
    J Pept Sci; 2007 Aug; 13(8):504-12. PubMed ID: 17617795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design of non-peptide human bradykinin B2 receptor antagonists employing the benzodiazepine peptidomimetic scaffold.
    Dziadulewicz EK; Brown MC; Dunstan AR; Lee W; Said NB; Garratt PJ
    Bioorg Med Chem Lett; 1999 Feb; 9(3):463-8. PubMed ID: 10091703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New bradykinin analogues modified in the C-terminal part with sterically restricted 1-aminocyclohexane-1-carboxylic acid.
    Labudda-Dawidowska O; Wierzba TH; Prahl A; Kowalczyk W; Gawiński Ł; Plackova M; Slaninová J; Lammek B
    J Med Chem; 2005 Dec; 48(25):8055-9. PubMed ID: 16335929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel analogues of bradykinin conformationally restricted in the C-terminal part of the molecule.
    Sleszyńska M; Wierzba TH; Malinowski K; Borovičková L; Małuch I; Sobolewski D; Lammek B; Slaninová J; Prahl A
    J Pept Sci; 2011 May; 17(5):366-72. PubMed ID: 21412955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
    J Med Chem; 1998 Nov; 41(23):4587-98. PubMed ID: 9804698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
    Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA
    J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus.
    Ballet S; De Wachter R; Van Rompaey K; Tömböly C; Feytens D; Töth G; Quartara L; Cucchi P; Meini S; Tourwé D
    J Pept Sci; 2007 Mar; 13(3):164-70. PubMed ID: 17266049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel design of bicyclic beta-turn dipeptides on solid-phase supports and synthesis of [3.3.0]-Bicyclo([2,3])-leu-enkephalin analogues.
    Gu X; Ying J; Agnes RS; Navratilova E; Davis P; Stahl G; Porreca F; Yamamura HI; Hruby VJ
    Org Lett; 2004 Sep; 6(19):3285-8. PubMed ID: 15355033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New conformationally homogeneous beta-turn antagonists of the human B2 kinin receptor.
    Monteagudo ES; Calvani F; Catrambone F; Fincham CI; Madami A; Meini S; Terracciano R
    J Pept Sci; 2001 May; 7(5):270-83. PubMed ID: 11428548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the B2 receptor and activity of bradykinin analogs in SHP-77 cell line by Cytosensor microphysiometer.
    Bironaite D; Gera L; Stewart JM
    Chem Biol Interact; 2004 Dec; 150(3):283-93. PubMed ID: 15560894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958.
    Gera L; Stewart JM; Fortin JP; Morissette G; Marceau F
    Int Immunopharmacol; 2008 Feb; 8(2):289-92. PubMed ID: 18182242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activities of new side chain and backbone cyclic bradykinin analogues.
    Schumann C; Seyfarth L; Greiner G; Paegelow I; Reissmann S
    J Pept Res; 2002 Aug; 60(2):128-40. PubMed ID: 12102726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity.
    Miskolzie M; Gera L; Stewart JM; Kotovych G
    J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor.
    Bélanger S; Bovenzi V; Côté J; Neugebauer W; Amblard M; Martinez J; Lammek B; Savard M; Gobeil F
    Peptides; 2009 Apr; 30(4):777-87. PubMed ID: 19111586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analogues of arginine vasopressin modified in position 2 and 3 with conformationally constrained dipeptide fragments.
    Łempicka E; Derdowska I; Kowalczyk W; Dawidowska O; Prahl A; Janecki M; Jasiński T; Trzeciak HI; Lammek B
    J Pept Sci; 2005 Feb; 11(2):91-6. PubMed ID: 15635636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1beta synthesis.
    Oppong KA; Ellis CD; Laufersweiler MC; O'Neil SV; Wang Y; Soper DL; Baize MW; Wos JA; De B; Bosch GK; Fancher AN; Lu W; Suchanek MK; Wang RL; Demuth TP
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4291-4. PubMed ID: 16046125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New bradykinin analogues substituted in positions 7 and 8 with sterically restricted 1-aminocyclopentane-1-carboxylic acid.
    Labudda O; Wierzba T; Sobolewski D; Kowalczyk W; Sleszyńska M; Gawiński L; Plackova M; Slaninová J; Prahl A
    J Pept Sci; 2006 Dec; 12(12):775-9. PubMed ID: 17131289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.